Abstract

Covid-19 disease is a worldwide pandemic outbreak involving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Obesity is known as one of the risk factors at the severity in Covid-19 patients. This is evidenced in the provision of intensive care (ICU) in hospitals or in health care institutions filled with obese patients with a BMI of >25 kg / m2. The impact of obesity often jack up the jeopardy of non-communicable diseases, cardiovascular disorders, cancer, diabetes melitus and non-alcoholic fatty liver disease and this often comes together from each individual. This is a non-systematic literature review article created with the collection of various recent scientific articles related to obesity, hypertension, and Covid-19 disease. A search for this article was obtained from NCBI, Web of Science and Google Scholar with keywords used: "Obesity and Covid-19", "Morbid Obesity", "Hypertension", "Comorbidities" and a combination of these keywords. There were 14 core articles. Obesity has been correleted to adaptive immunity dysregulation and failure in antibody formation after infection or vaccination. Thus, the effect of obesity on a person's immunity is said to be important in the severity of the Covid-19 disease

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.